Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).

Autor: Soria-Juan B; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Garcia-Arranz M; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Llanos Jiménez L; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain. lucia.llanos@quironsalud.es., Aparicio C; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Gonzalez A; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Mahillo Fernandez I; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Riera Del Moral L; La Paz University Hospital, Madrid, Spain., Grochowicz L; Navarra University Clinic, Pamplona, Navarra, Spain., Andreu EJ; Navarra University Clinic, Pamplona, Navarra, Spain., Marin P; Virgen de la Arrixaca University Hospital, Murcia, Spain., Castellanos G; Virgen de la Arrixaca University Hospital, Murcia, Spain., Moraleda JM; Virgen de la Arrixaca University Hospital, Murcia, Spain., García-Hernández AM; Virgen de la Arrixaca University Hospital, Murcia, Spain., Lozano FS; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Sanchez-Guijo F; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Villarón EM; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Parra ML; IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain., Yañez RM; Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain., de la Cuesta Diaz A; Queen Victoria Eugenia-Cruz Roja Hospital, Sevilla, Spain., Tejedo JR; University of Pablo de Olavide, Sevilla, Spain., Bedoya FJ; University of Pablo de Olavide, Sevilla, Spain.; Network Center for Research in Diabetes and Associated Metabolic Diseases (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas-CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Martin F; University of Pablo de Olavide, Sevilla, Spain., Miralles M; La Fe University Hospital, Valencia, Spain., Del Rio Sola L; Valladolid Clinical University Hospital, Valladolid, Spain., Fernández-Santos ME; Institute for Health Research Gregorio Marañón (IISGM), General University Gregorio Marañón Hospital, Madrid, Spain., Ligero JM; Institute for Health Research Gregorio Marañón (IISGM), General University Gregorio Marañón Hospital, Madrid, Spain., Morant F; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain., Hernández-Blasco L; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain., Andreu E; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.; University Miguel Hernández de Elche, Alicante, Spain., Hmadcha A; University of Pablo de Olavide, Sevilla, Spain.; The Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain.; University of Alicante, Alicante, Spain., Garcia-Olmo D; Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain., Soria B; University of Pablo de Olavide, Sevilla, Spain.; Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.; University Miguel Hernández de Elche, Alicante, Spain.

Publikováno v: Trials [Trials] 2021 Sep 06; Vol. 22 (1), pp. 595. Date of Electronic Publication: 2021 Sep 06.

[Review of the actions in prevention of infections in total arthroplasty of hip].

Autor: Galindo MM; Centro Médico ABC., Kochen JA, Parra ML, Muñoz PM

Publikováno v: Acta ortopedica mexicana [Acta Ortop Mex] 2007 Nov-Dec; Vol. 21 (6), pp. 328-32.

[Evaluation of psychological and social rehabilitation of the child with chronic renal failure].

Autor: Velasco de Parra ML, González L, Santoyo E

Publikováno v: Boletin medico del Hospital Infantil de Mexico [Bol Med Hosp Infant Mex] 1980 Jan-Feb; Vol. 37 (1), pp. 51-62.